Lee S. Schwartzberg MD, FACP, MS

Lee S. Schwartzberg, MD, is the Executive Director of the West Cancer Center, a multispecialty oncology practice affiliated with the University of Tennessee comprising over 50 medical oncologists, gynecologic oncologists, radiation oncologists, surgical oncologists, palliative care experts, radiologists and other oncology-related physicians located in Memphis, Tennessee. Dr. Schwartzberg also serves as Professor of Medicine and Division Chief of Hematology/Oncology at The University of Tennessee Health Science Center.

Dr. Schwartzberg received his medical degree from New York Medical College. After completing his internal medicine residency at Cornell University/North Shore University Hospital, Dr. Schwartzberg continued his training with a medical oncology and hematology fellowship at Memorial Sloan Kettering Cancer Center (MSKCC). During his tenure at MSKCC, Dr. Schwartzberg served as Chief Medical Resident and was a founding member of the institutional ethics committee.

Dr. Schwartzberg's specializes in the treatment of breast cancer, with a specific research focus on new therapeutic approaches, targeted therapy, and supportive care. Dr. Schwartzberg has published more than 190 peer-reviewed articles in peer-reviewed journals, including Journal of Clinical Oncology, Lancet Oncology, and Annals of Oncology.

Dr. Schwartzberg was the founding editor-in-chief of the journal Community Oncology and currently serves as the editor-in-chief of the Practice Update Oncology website. He serves on the editorial board of both the Journal of Supportive Oncology and The ASCO Post, in addition to serving as a reviewer for many prominent medical journals, including The New England Journal of Medicine and Journal of Clinical Oncology.

Dr. Schwartzberg serves on the NCCN Board of Directors and the NCCN Guidelines Steering Committee. He also is a member of the NCCN Breast Cancer Panel, the NCCN Myeloid Growth Factors Panel, and the NCCN Antiemesis Panel. Additionally, Dr. Schwartzberg is a member of the NCCN Oncology Research Program Investigator Steering Committee.